The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chari Family Trust
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE has received a disclosure under Regulation 29(1) and 29(2) of SEBI's Substantial Acquisition of Shares & Takeovers Regulations, 2011, filed by Chari Family Trust, a promoter-group entity of Rossari Biotech. This regulation requires promoters and persons acting in concert to report any creation, invocation, or release of encumbrances (such as pledges) on shares, as well as changes in their shareholding. The specific nature of the disclosure — whether it pertains to a pledge, stake change, or other encumbrance — and the exact quantum involved are not detailed in this filing notice.
Without specifics on the transaction type and size, investors cannot immediately gauge the implications for promoter holding or stock price. Investors should watch for the detailed disclosure or follow-up announcement from Rossari Biotech to understand whether this affects promoter shareholding or pledged shares.